H. Xiang

[Efficacy and safety of domestic dasatinib as second-line treatment for chronic myeloid leukemia patients in the chronic phase].

L. Meng, Z. Zhao, Y. L. Chen, 2019, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China

Yadan Wang, Chun Zhang, Hongxiang Wang, 2020, Leukemia & lymphoma.

Recommendations for standardized management of CML patients in the core epidemic area of COVID-19(Multi-center survey results in Hubei Province, China)

Q. Li, D. Wang, X. Zuo, 2020, medRxiv.

The First Report of the Prevalence of COVID-19 in Chronic Myelogenous Leukemia Patients in the Core Epidemic Area of China: A Multicentre, Cross-Sectional Survey

L. Meng, Youlin Zhao, Zhuangzhi Yang, 2020 .

COVID-19 in persons with chronic myeloid leukaemia

Q. Jiang, Zhuangzhi Yang, Hongxiang Wang, 2020, Leukemia.

SARS-CoV-2 Omicron BA.5.2-infection and COVID-19 in persons with chronic myeloid leukaemia.

R. Gale, Qiubai Li, F. Cheng, 2023, Journal of cancer research and clinical oncology.

The predictive value of regulatory T cells on glucocorticoid sensitivity in patients with immune thrombocytopenia: a multicentre, prospective clinical study

Donghua Zhang, Jia Wei, Kaibo Gao, 2021, British journal of haematology.